CUE
Cue Biopharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$18.84
−9.68%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 136.86x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 59.25x
- Price / sales
- 3.63x
- Price / cash flow
- -2.73x
Enterprise value
- Enterprise value
- $128.3M
- EV / sales
- 3.41x
- EV / EBITDA
- -1.34x
- EV / EBIT
- -1.30x
- Market cap
- $136.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026